Quantification of EAAT2 labeling density performed based on fluorescence IHC experiments (Figures 2, 4) did not reveal any statistically significant differences between AD and control brains in any of the brain regions investigated (Figures 6A–G). This evidence concerns the gene SLC1A2 and Alzheimer disease.